{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:44:19Z","timestamp":1776131059079,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108464","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:59:14Z","timestamp":1770479954000},"page":"108464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Letter to Editor: Rattanaumpawan et al. Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-8647","authenticated-orcid":false,"given":"Vianney","family":"Tricou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuri","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Xiang","family":"Setoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phatraporn","family":"Assawawongprom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sonnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Livengood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Zent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibadas","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Kandeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108464_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108062","article-title":"Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: a case report of a potential vaccine-associated adverse reaction","volume":"160","author":"Rattanaumpawan","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108464_bib0002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/14760584.2025.2490295","article-title":"TAK-003: development of a tetravalent dengue vaccine","volume":"24","author":"S\u00e1ez-Llorens","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2026.108464_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2025.101202","article-title":"Seroepidemiological surveillance of neutralizing antibodies against dengue virus serotypes among healthy adults in Bangkok, Thailand","volume":"21","author":"Nindee","year":"2025","journal-title":"One Health"},{"key":"10.1016\/j.ijid.2026.108464_bib0004","unstructured":"CDC. Clinical testing guidance for dengue, https:\/\/www.cdc.gov\/dengue\/hcp\/diagnosis-testing\/index.html; 2025 [accessed 19 November 2025]."},{"issue":"7","key":"10.1016\/j.ijid.2026.108464_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101088","article-title":"Evaluating the performance of common reference laboratory tests for acute dengue diagnosis: a systematic review and meta-analysis of RT-PCR, NS1 ELISA, and IgM ELISA","volume":"6","author":"Pillay","year":"2025","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.ijid.2026.108464_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4269\/ajtmh.23-0549","article-title":"IgG, IgM, and nonstructural protein 1 response profiles after receipt of tetravalent dengue vaccine tak-003 in a phase 2 randomized controlled trial","volume":"111","author":"Low","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2026.108464_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2005.06.019","article-title":"Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA","volume":"131","author":"Butrapet","year":"2006","journal-title":"J Virol Methods"},{"issue":"4","key":"10.1016\/j.ijid.2026.108464_bib0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","article-title":"A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone","volume":"15","author":"Osorio","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2026.108464_bib0009","series-title":"Presented at: American Society of Tropical Medicine & Hygiene Annual Meeting; November 9-13","article-title":"Comprehensive safety evaluation of Takeda\u2019s Dengue vaccine (TAK-003): insights from long-term clinical trials and postmarketing surveillance","author":"El Hindi","year":"2025"},{"key":"10.1016\/j.ijid.2026.108464_bib0010","series-title":"Presented at: Annual Meeting of the European Society for Paediatric Infectious Diseases; May 20-24","article-title":"Safety of Takeda\u2019s tetravalent dengue vaccine candidate (TAK-003) in participants with detectable vaccine viremia: combined results from the TAK-003 Clinical Development program","author":"Tricou","year":"2024"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:50:42Z","timestamp":1776127842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":10,"alternative-id":["S1201971226000998"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108464","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to Editor: Rattanaumpawan et al. Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108463","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108062","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108464"}}